Format

Send to

Choose Destination
Clin Lung Cancer. 2013 Sep;14(5):592-5. doi: 10.1016/j.cllc.2013.04.008. Epub 2013 Jun 27.

A case series of lengthy progression-free survival with pemetrexed-containing therapy in metastatic non--small-cell lung cancer patients harboring ROS1 gene rearrangements.

Author information

1
Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. riessjo@stanford.edu

KEYWORDS:

Chemotherapy; Molecular subtypes; NSCLC; Pemetrexed; ROS1

PMID:
23810364
PMCID:
PMC4156821
DOI:
10.1016/j.cllc.2013.04.008
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center